Adverse events of nucleos(t)ide analogues for chronic hepatitis B: a systematic review

Nucleos(t)ide analogues (NAs) are the main drug category used in chronic hepatitis B (CHB) treatment. Despite the fact that NAs have a favourable safety profile, undesired adverse events (AEs) may occur during the treatment of CHB. Given the eminent number of patients currently receiving NAs, even a...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Gastroenterol
Hlavní autoři: de Fraga, Raquel Scherer, Van Vaisberg, Victor, Mendes, Luiz Cláudio Alfaia, Carrilho, Flair José, Ono, Suzane Kioko
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer Singapore 2020
Témata:
Review
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7188775/
https://ncbi.nlm.nih.gov/pubmed/32185517
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00535-020-01680-0
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky